Clinical trial
The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study
NCT00105027 · The Emmes Company, LLC, Industry · Completed
Key facts
| NCT number | NCT00105027 |
|---|---|
| Title | The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study |
| Official title | The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide With Standard Care to Treat Macular Edema |
| Acronym | SCORE |
| Lead sponsor | The Emmes Company, LLC, Industry |
| Collaborators | National Eye Institute (NEI) NIH Allergan Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Edema, Cystoid, Retinal Vein Occlusion |
| Intervention type | Drug, Other |
| Interventions | Standard Care, intravitreal triamcinolone injection |
| Enrollment | 682 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Mar 4, 2005 |
| Last update posted | Jul 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: